Eli Lilly participates in £90 million ($114 million) Series A financing of Myricx
Client(s) Eli Lilly and Company
Jones Day advised Eli Lilly and Company in connection with the £90 million ($114 million) Series A financing of Myricx, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs).